Financial Snapshot

Revenue
$273.7K
TTM
Gross Margin
94.16%
TTM
Net Earnings
-$873.0K
TTM
Current Assets
Q1 2024
Current Liabilities
Q1 2024
Current Ratio
8.18%
Q1 2024
Total Assets
Q1 2024
Total Liabilities
Q1 2024
Book Value
-$4.874M
Q1 2024
Cash
Q1 2024
P/E
-7.281
Nov 11, 2024 EST
Free Cash Flow
-$462.3K
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue $204.3K $104.6K $195.7K $5.470K $0.00 $0.00 $0.00 $0.00 $43.37K $0.00
YoY Change 95.23% -46.52% 3477.15% -100.0%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue $204.3K $104.6K $195.7K $5.470K $0.00 $0.00 $0.00 $0.00 $43.37K $0.00
Cost Of Revenue $35.72K $1.588M $144.3K $3.370K $0.00 $0.00 $0.00 $0.00 $59.31K $0.00
Gross Profit $168.6K -$1.484M $51.35K $2.100K $0.00 $0.00 $0.00 $0.00 -$15.94K $0.00
Gross Profit Margin 82.52% -1417.9% 26.24% 38.39% -36.75%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Selling, General & Admin $661.2K $3.250M $294.9K $48.26K $46.77K $58.15K $48.37K $0.00 $644.2K $353.3K
YoY Change -79.66% 1002.13% 511.09% 3.19% -19.57% 20.22% -100.0% 82.33%
% of Gross Profit 392.22% 574.31% 2298.1%
Research & Development $0.00
YoY Change
% of Gross Profit
Depreciation & Amortization $10.35K $5.905K $0.00
YoY Change 75.21%
% of Gross Profit 6.14% 0.0%
Operating Expenses $661.2K $3.250M $294.9K $48.26K $46.77K $58.15K $48.37K $0.00 $644.2K $353.3K
YoY Change -79.66% 1002.13% 511.09% 3.19% -19.57% 20.22% -100.0% 82.33%
Operating Profit -$492.6K -$4.734M -$243.6K -$46.16K -$46.77K -$58.15K -$48.37K $0.00 -$660.1K -$353.3K
YoY Change -89.59% 1843.71% 427.64% -1.3% -19.57% 20.22% -100.0% 86.85%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Interest Expense $319.7K $190.9K -$25.49K -$4.970K -$17.47K -$440.00 $0.00
YoY Change 67.46% -848.98% 412.88% -71.55% 3870.45%
% of Operating Profit
Other Income/Expense, Net -$284.7K -$190.8K -$25.49K $0.00
YoY Change 49.18% 648.56%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Pretax Income -$777.3K -$4.925M -$269.1K -$51.12K -$64.24K -$58.59K -$48.37K $0.00 -$660.1K -$353.3K
YoY Change -84.22% 1730.49% 426.31% -20.42% 9.64% 21.13% -100.0% 86.85%
Income Tax $0.00 $800.00 $800.00 $800.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$777.3K -$4.925M -$269.1K -$51.92K -$65.04K -$59.39K -$967.0K -$1.141M -$644.5K -$353.3K
YoY Change -84.22% 1730.49% 418.2% -20.17% 9.51% -93.86% -15.24% 77.02% 82.44%
Net Earnings / Revenue -380.47% -4706.19% -137.5% -949.18% -1486.14%
Basic Earnings Per Share
Diluted Earnings Per Share $0.00 -$230.70 -$13.16 -$2.57 -$3.21 -$2.94 -$47.91 -$56.91 -$32.26 -$17.68

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Cash & Short-Term Investments $54.15K $62.64K $396.1K $170.00 $100.00 $20.00 $3.830K $0.00 $24.28K $0.00
YoY Change -13.55% -84.19% 232923.53% 70.0% 400.0% -99.48% -100.0%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $16.96K $16.96K $18.30K $0.00 $249.5K $0.00
YoY Change 0.0% -7.32% -100.0%
Inventory $108.4K $116.1K $7.850K $1.140K $0.00
Prepaid Expenses
Receivables $0.00 $920.00 $0.00 $0.00
Other Receivables $0.00 $0.00 $61.14K $0.00
Total Short-Term Assets $179.5K $196.6K $483.4K $3.890K $100.00 $120.00 $3.930K $249.5K $24.28K $0.00
YoY Change -8.71% -59.33% 12327.25% 3790.0% -16.67% -96.95% -98.42% 927.43%
Property, Plant & Equipment $99.61K $117.5K $139.6K
YoY Change -15.23% -15.83%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $0.00 $12.98K
YoY Change -100.0%
Other Assets $11.84K $13.84K $700.00
YoY Change -14.45% 1877.14%
Total Long-Term Assets $119.7K $139.6K $139.6K $0.00 $0.00 $12.97K $0.00 $0.00 $0.00 $0.00
YoY Change -14.25% -0.04% -100.0%
Total Assets $299.1K $336.1K $623.0K $3.890K $100.00 $13.09K $3.930K $249.5K $24.28K $0.00
YoY Change
Accounts Payable $1.451M $1.438M $57.21K $49.27K $38.90K $20.02K $0.00 $30.00K
YoY Change 0.91% 2412.71% 16.12% 26.66% 94.31% -100.0%
Accrued Expenses $41.92K $70.90K $50.67K $7.900K $0.00 $400.0K
YoY Change -40.87% 39.93% -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $705.2K $183.9K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $10.00K $0.00
YoY Change 283.42% -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.092M $2.757M $432.4K $218.9K $168.1K $120.6K $51.99K $174.6K $481.3K $38.66K
YoY Change 12.13% 537.66% 97.55% 30.22% 39.44% 131.87% -70.22% -63.72% 1144.85%
Long-Term Debt $1.123M $1.032M $582.2K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change 8.82% 77.29%
Other Long-Term Liabilities $609.9K $407.1K $76.26K $0.00 $1.168M $535.4K $314.6K
YoY Change 49.83% 433.78% -100.0% 118.19% 70.17%
Total Long-Term Liabilities $1.733M $1.439M $658.4K $0.00 $0.00 $0.00 $0.00 $1.168M $535.4K $314.6K
YoY Change 20.42% 118.58% -100.0% 118.19% 70.17%
Total Liabilities $4.750M $4.138M $1.091M $218.9K $168.1K $120.6K $51.99K $1.343M $1.022M $353.3K
YoY Change 14.8% 279.32% 398.33% 30.22% 39.44% 131.87% -96.13% 31.37% 189.31%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Basic Shares Outstanding
Diluted Shares Outstanding
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $6.3567 Million

About America Great Health

America Great Health focuses on protein and peptide small molecular drugs research and development, diagnostic and medical devices with AI cloud computing, cell therapy, and regenerational medicine and supplements manufacturing and sales. The company is headquartered in Alhambra, California and currently employs 7 full-time employees. The company went IPO on 2012-06-18. The firm is focused on protein and peptide small molecular drugs research and development, diagnostic and medical devices with artificial intelligence (AI) cloud computing, cell therapy, and re-generational medicine and supplement manufacturing and sales. The company is also focused on investing in innovative technologies, integrated with business development in the healthcare ecosystem.

Industry: Pharmaceutical Preparations Peers: